PROFUSA, INC. Accrued Liabilities, Current
PROFUSA, INC. (PFSA) had Accrued Liabilities, Current of $6.22 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-19
- 2026-06-30: Accrued Liabilities, Current $6.22M.
- 2026-03-31: Accrued Liabilities, Current $6.18M.
- 2025-12-31: Accrued Liabilities, Current $5.98M.
- 2025-09-30: Accrued Liabilities, Current $7.85M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.22M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $6.18M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.98M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $7.85M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $1.74M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $933.87K 10-Q · filed 2025-06-13 | |
| 2024-12-31 | $3.97M S-1/A · filed 2026-05-01 | $684.48K 10-K · filed 2025-03-31 |
| 2024-09-30 | $726.98K 10-Q · filed 2024-12-17 | |
| 2024-06-30 | $704.83K 10-Q · filed 2024-11-15 | |
| 2024-03-31 | $614.29K 10-Q · filed 2024-10-09 | |
| 2023-12-31 | $449.11K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $448.48K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |